Toxicological assessment of magnesium oxide nanoparticles in HT29 intestinal cells

被引:0
作者
Anna Mittag
Thomas Schneider
Martin Westermann
Michael Glei
机构
[1] Friedrich Schiller University Jena,Department of Nutritional Toxicology, Institute of Nutritional Sciences
[2] Friedrich Schiller University Jena,Electron Microscopy Centre
来源
Archives of Toxicology | 2019年 / 93卷
关键词
Flow cytometry; HT29 cells; Magnesium oxide; Nanoparticles; Nanotoxicology; Oral exposure;
D O I
暂无
中图分类号
学科分类号
摘要
Nanoparticles (NPs) are increasingly used in different consumer-related areas, for instance in food packaging or as additives, because of their enormous potential. Magnesium oxide (MgO) is an EU-approved food additive (E number 530). It is commonly used as a drying agent for powdered foods, for colour retention or as a food supplement. There are no consistent results regarding the effects of oral MgO NP uptake. Consequently, the aim of this study was to examine the effects of MgO NPs in the HT29 intestinal cell line. MgO NP concentrations ranged from 0.001 to 100 μg/ml and incubation times were up to 24 h. The cytotoxic and genotoxic potential were investigated. Apoptotic processes and cell cycle changes were analysed by flow cytometry. Finally, oxidative stress was examined. Transmission electron microscopy indicated that there was no cellular uptake. MgO NPs had no cytotoxic or genotoxic effects in HT29 cells and they did not induce apoptotic processes, cell cycle changes or oxidative stress.
引用
收藏
页码:1491 / 1500
页数:9
相关论文
共 169 条
[31]  
Hanes J(2005)Is nano safe in foods? Establishing the factors impacting the gastrointestinal fate and toxicity of organic and inorganic food-grade nanoparticles FASEB J 281 301-R462
[32]  
Ensign LM(2005)Functional improvement in rats’ pancreatic islets using magnesium oxide nanoparticles through antiapoptotic and antioxidant pathways Risk Anal 24 230-474
[33]  
De Matteis V(2016)Nanomedicine: current status and future prospects RSC Adv 24 R453-3914
[34]  
DeLoid GM(2004)Development of a preliminary framework for informing the risk analysis and risk management of nanoparticles Methods Mol Biol 48 465-73
[35]  
Cohen JM(2008)Nanoparticles as transfection agents: a comprehensive study with ten different cell lines Curr Opin Gastroenterol 30 3891-18
[36]  
Pyrgiotakis G(2014)Analysis of cell cycle by flow cytometry Curr Biol 77 64-342
[37]  
Demokritou P(2017)Recent developments in intestinal magnesium absorption Arch Toxicol 4 8-40
[38]  
Elsaesser A(2015)ROS function in redox signaling and oxidative stress Cell Prolif 27 333-82
[39]  
Howard CV(2009)In vitro uptake and toxicity studies of metal nanoparticles and metal oxide nanoparticles in human HT29 cells Biomaterials L275 38-356
[40]  
Emerich DF(2015)Independent effect of polymeric nanoparticle zeta potential/surface charge, on their cytotoxicity and affinity to cells Food Chem Toxicol 28 78-334